EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -0.0008
March 31, 2026 -0.0006
December 31, 2025 -0.0035
September 30, 2025 -0.0002
June 30, 2025 -0.0012
March 31, 2025 -0.0025
December 31, 2024 -0.0043
September 30, 2024 -0.0022
June 30, 2024 -0.0017
March 31, 2024 -0.0022
December 31, 2023 -0.0035
September 30, 2023 -0.0037
June 30, 2023 -0.0025
March 31, 2023 -0.0062
December 31, 2022 -0.0115
September 30, 2022 -0.0039
June 30, 2022 -0.0041
March 31, 2022 -0.0131
December 31, 2021 -0.0474
September 30, 2021 -0.0048
Date Value
June 30, 2021 -0.0058
March 31, 2021 -0.0251
December 31, 2020 -0.007
September 30, 2020 -0.0214
June 30, 2020 -0.0028
March 31, 2020 -0.0003
December 31, 2019 0.00
June 30, 2019 -0.0003
March 31, 2019 0.0031
December 31, 2018 -0.0004
September 30, 2018 -0.0019
June 30, 2018 -0.0018
March 31, 2018 -0.0068
December 31, 2017 -0.0088
September 30, 2017 -0.0018
June 30, 2017 -0.0022
March 31, 2017 -0.0019
December 31, 2016 -0.0009
September 30, 2016 -0.0025
June 30, 2016 -0.0008

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Vyome Holdings, Inc. -0.0977
Abbott Laboratories 0.5324
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832

EPS Diluted (Quarterly) Related Metrics